AngioDynamics Inc. (NASDAQ: ANGO) reported first quarter 2021 earnings results today. Net sales increased 6.3% to $70.2 million but were impacted by the disruption to procedure volumes due to the COVID-19 pandemic. The company recorded a net loss of $4.3 million, or $0.11 per share, compared to a net loss of approx. $1.3 million, or $0.03 […]
“AngioDynamics Inc. (NASDAQ: ANGO) reported first quarter 2021 earnings results today. Net sales increased 6.3% to $70.2 million but were impacted by the disruption to procedure volumes due to the COVID-19 pandemic. The company recorded a net loss of $4.3 million, or $0.11 per share, compared to a net loss of approx. $1.3 million, or $0.03 […]
· September 29, 2020
AngioDynamics Inc. (NASDAQ: ANGO) reported first quarter 2021 earnings results today.
Net sales increased 6.3% to $70.2 million but were impacted by the disruption to procedure volumes due to the COVID-19 pandemic.
The company recorded a net loss of $4.3 million, or $0.11 per share, compared to a net loss of approx. $1.3 million, or $0.03 per share, a year ago. Adjusted net income was $0.6 million, or $0.02 per share.
AngioDynamics expects fiscal year 2021 net sales to be in the range of $278-284 million and adjusted EPS to be $0.00 to $0.05.
